PTPRK and colorectal carcinoma: Importantly, in 2012 it was found that 4–10% of CRC patients harbor gene fusions of the RSPO2 and RSPO3 genes with EIF3E and PTPRK respectively, co-occurring with enhanced expression of the considerate RSPO gene [49, 50].